331712 RESULTS
GRANT Friday, May 3, 2024- 3:45pm National Institutes of Health This Notice of Special Interest (NOSI) solicits competitive revision applications. Multiple due dates; see announcement. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-24-096.html 04 Nov 2
GRANT Friday, May 3, 2024- 3:30pm National Center for Advancing Translational Sciences Two identical technical assistance webinars will be conducted. 1) May 22, 2024 – 9:00 am to 10:30 am Eastern Time. 2) June 3, 2024 – 3:00 pm to 4:30 pm Eastern Time. https://
Brandeis UniversityWaltham, United States
COMMENT This is a very nice study from the DIAN-TU team, reporting the effects of anti-amyloid therapy with gantenerumab and solanezumab on CSF and plasma biomarkers as measured by the Roche NeuroToolKit in dominantly inherited Alzheimer’s disease. Although the s
RESEARCH NEWS 2024-05-03 Research News Scientists still have much to learn about how Aβ immunotherapy affects downstream processes in the brain. In the April 29 JAMA Neurology, researchers led by Eric McDade at Washington University School of Medicine, St. Louis, offer some hints
PAPER Meng Q, Chen C, Zhu M, Huang Y
PAPER Mughal ZU, Ahmed B, Amin F, Sadiq A, Rangwala BS
PAPER Tang Z, Zhang T, Song Q, Su J, Yang B
PAPER Jaye S, Sandau US, Saugstad JA
PAPER Böing C, Di Fabrizio M, Burger D, Bol JG, Huisman E, Rozemuller AJ, van de Berg WD, Stahlberg H, Lewis AJ
PAPER He M, Zhang X, Ran X, Zhang Y, Nie X, Xiao B, Lei L, Zhai S, Zhu J, Zhang J, Li R, Liu Z, Zhu Y, Dai Z, He Z, Feng J, Zhang C
PAPER Kolmakova KA, Lobzin VY, Emelin AY, Litvinenko IV
PAPER Marier A, Dadar M, Bouhali F, Montembeault M, Alzheimer’s Disease Neuroimaging Initiative
PAPER Golimstok Á, Basalo MJ, Majul M, Berrios W, Rugiero M, Fernández MC, Eichel R
PAPER Xu Y, Xu M, Zhou C, Sun L, Cai W, Li X
No filters selected
